Analytical Quality by Design-driven Reversed Phase – High Performance Liquid Chromatography Method and Risk Mitigation for Fimasartan
Biosciences Biotechnology Research Asia · 31.03.2026 · 1 (23) · 204
DOI: 10.13005/bbra/3491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosciences Biotechnology Research Asia, online erschienen am 30.03.2026. Verfasst von Kajal Baviskar und 2 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The study covers the Analytical Quality by Design driven method for the determining Fimasartan, an antihypertensive drug. Critical Quality Attributes, namely, retention time, peak area and theoretical plates, were identified and assessed for method performance. An Ishikawa diagram along with Failure Mode Effects Analysis were employed to analyze risk and identify variables having a significant impact on method performance as well as reliability. Critical Method Variables, namely, mobile phase composition, flow rate, and detection wavelength, were systematically optimized. The chromatographic conditions after optimization were methanol proportion in mobile phase: 79.59%v/v, flow rate of 0.8 mL min-1 and detection wavelength 264 nm. These conditions resulted in a response time of 5.5 min., with adequate system suitability, comprising adequate theoretical plates and peak symmetry. Validation of optimized method was accomplished using the ICH Q2 (R1) guidelines with consideration of recent revisions in Q2(R2)., displaying high linearity, accuracy, precision, and robustness. Precision data revealed that %RSD values that were well within acceptable ranges, indicating reproducibility of the method. Integration of Analytical Quality by Design allowed for a comprehensive understanding of method variability and control techniques. Such techniques can be utilized for chromatographic estimation of other drugs.
Zitieren
APA
Baviskar, K., Kachave, R., & Chavan, M. (2026). Analytical Quality by Design-driven Reversed Phase – High Performance Liquid Chromatography Method and Risk Mitigation for Fimasartan. Biosciences Biotechnology Research Asia, 1(23), 204. https://doi.org/10.13005/bbra/3491
Vancouver
Baviskar K, Kachave R, Chavan M. Analytical Quality by Design-driven Reversed Phase – High Performance Liquid Chromatography Method and Risk Mitigation for Fimasartan. Biosciences Biotechnology Research Asia. 2026;1(23):204. doi:10.13005/bbra/3491
BibTeX
@article{Baviskar2026,
author = {Baviskar, Kajal and Kachave, Ramanlal and Chavan, Machindra},
title = {Analytical Quality by Design-driven Reversed Phase – High Performance Liquid Chromatography Method and Risk Mitigation for Fimasartan},
journal = {Biosciences Biotechnology Research Asia},
year = {2026},
volume = {1},
number = {23},
pages = {204},
doi = {10.13005/bbra/3491}
}
EUVIMED